Biosimilars for the treatment of psoriasis-Reference-Cited by-同舟云学术

Biosimilars for the treatment of psoriasis

Published:2019-07-01 Issue:10 Volume:19 Page:993-1000
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Puig Lluís¹^ORCID,López-Ferrer Anna¹

Affiliation:

1. Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Funder

not funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2019.1636963

Reference49 articles.

1. Organization WH. Global report on psoriasis. World Health Organization; s2016. [accessed on 2019 May 4]. Available from: https://apps.who.int/iris/handle/10665/204417.

2. Guidelines of care for the management of psoriasis and psoriatic arthritis

3. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics

4. Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Documento de consenso sobre los medicamentos biosimilares en enfermedades inmunomediadas en España;Reumatología Clínica;2023-10

2. Consensus statement on the use of biosimilar drugs in immune-mediated diseases in Spain;Reumatología Clínica (English Edition);2023-10

3. Current and emerging prospects in the psoriatic treatment;International Immunopharmacology;2023-07

4. [Translated article] Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis;Actas Dermo-Sifiliográficas;2023-06

5. Actualización en el posicionamiento del Grupo Español de Psoriasis (GPS) en la utilización de medicamentos biosimilares en psoriasis moderada-grave;Actas Dermo-Sifiliográficas;2023-06